Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Ultrasound Med Biol. 2017 Oct 26;44(1):37–70. doi: 10.1016/j.ultrasmedbio.2017.09.012

Table 4.

Diagnostic performance of multiple imaging modalities in breast lymph nodes


Author Year Accrual period Subject number of research Mammogra phy US MRI PET

(Zhang, et al. 2015) 2010–2011 1.049 breast cancers - SE=69.4:SP=81.8:Accuracv=77 - -

(Xin. et al. 2014) 2012–2013 323 female primary
breast cancer
SE=35.6;SP=98.9:PPV=35.6;NPV=68.3

(Alvarez, et al. 2006) 1980–2004 Meta analysis with
Sixteen articles
Cnterion Non-palpable Palpable +non- palpable - -

size<5 mm SE=48.8–87.7
SP=55.6–97.3
SE=66.1–72.7
SP=44.1–97.9

morphology SE=26.4–75.9
SP=SS.4–98.l
SE=54.7–92.3
SP=S0.4-87.1

(Valente, et al. 2012) 200S-2010 244 invasive breast carcinomas SE=21
SP= 99.5
SE=43.5
SP= 96.2
SE=37.1
SP= 96.7
-

(Heusner. et al. 2009) 2007–2008 61 patients with breast cancer FDG PET/CT
SE=5S;SP=92
PPV=82;NPV=77
Accuracy=79

(Kvistad. et al. 2000) 1998 65 patients with invasive breast cancer SE=83
SP= 90
Accuiac=88

(Lind. et al. 2004) Review of 1989– 2004 201 For local récurrence,
lymph node
métastasés and
distant métastasés
SE =96%:SP = 77%

(Song, et al. 2015) 2008-2012 86 invasive breast cancer SE = 36.4
SP =S6.8
SE = 61.4
SP =92.1
SE = 61.4
SP =73.7
FDG-PET
SE = 47.7;
SP =81.6

(Heusner. et al. 2008) 40 women with suspected breast cancer 18F-FDG PET/CT
SE = 0.80

(An. et al. 2015) 2008-2012 37 patients with breast cancer. For internal mammary LN
metastasis
Initial US SE=76.6
Initial US combined with SLUS SE=96.7
SE=92.9